| bioMérieux Introduces VITEK® 2 Compact
with Advanced Identification Technology
St. Louis, USA – March 16, 2005. A world leader in the field of in vitro diagnostics, bioMérieux completes its VITEK 2 range of automated microbial identification and susceptibility testing systems through the launch of VITEK 2 Compact.
The newly launched VITEK 2 Compact, a system for identification and antibiotic susceptibility testing, offers the same advantages as VITEK 2 in a more compact form.
Identification performance has been enhanced on VITEK 2 Compact systems through the introduction of “Advanced Colorimetric™” technology. An expanded database of over 330 species of microorganisms can be identified using the new VITEK 2 Compact Colorimetric Identification cards.
VITEK 2 Compact was launched for the US industrial markets in December, 2004 and will progressively be commercialized in all other countries for industrial customers.
VITEK 2 Compact offers a simple solution to the complex task of identification and is designed with features to enable complete compliance with 21 CFR, part 11 regulations.
About bioMérieux INDUSTRY
bioMérieux INDUSTRY provides product solutions to quality control and research microbiology laboratories. Applications served include environmental monitoring, sterility testing, pathogen screening, quality indicators, microbial identification, in-process quality control testing, microbial limits and preservative effectiveness testing.
About bioMérieux
A global leader in disease prevention and management, bioMérieux provides assays, reagents and instrumentation for clinical microbiology, coagulation, immunoassay, and nucleic acid diagnostics; and also for product quality control in the blood bank, agri-food, cosmetics and pharmaceutical industries. Based in Marcy-l'Etoile, France, the company's U.S. headquarters is in Durham, North Carolina.
With sales of 1 billion Euros in 2003, bioMérieux ranks as the eighth-largest biological diagnostics company worldwide. Over 81% of its activity takes place on an international level. Investment in research and development represents 13% of sales.
bioMérieux employs 5400 people throughout the world, including 3200 in Europe and 1500 in the U.S. The group has 15 production sites located in France, the United States, Brazil, Italy and the Netherlands, as well as a European logistics center in France. Already present in over 130 countries, with more than 110 distributors and 32 subsidiaries, bioMérieux continues its international development by strengthening its presence in Latin America and Asia.
View VITEK 2 Compact Brochure
Learn more about VITEK 2 Compact for:
Food
Pharmaceutical / Biotech
Cosmetics
Water Testing
Return to bioMérieux News |
